Evidence map›Paper›PMID 20094034›Full record

ArticleThe EMBO journal2010

The intronic splicing code: multiple factors involved in ATM pseudoexon definition.

Ashish Dhir, Emanuele Buratti, Maria A van Santen, Reinhard Lührmann, Francisco E Baralle

Abstract read
In one paragraph

Article in The EMBO journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Lessons from non-canonical splicing.Nature reviews. Genetics · 2016
    Review
  5. Article
  6. Article
  7. A day in the life of the spliceosome.Nature reviews. Molecular cell biology · 2014
    Review
  8. Article
  9. Role of pseudoexons and pseudointrons in human cancer.International journal of cell biology · 2013
    Review
  10. RNA splicing: a new player in the DNA damage response.International journal of cell biology · 2013
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ashish DhirMolecular Pathology Group, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Emanuele Buratti
Maria A van Santen
Reinhard Lührmann
Francisco E Baralle

Funding

Telethon GGP06147
6 · The paper itself

Abstract

Abundance of pseudo splice sites in introns can potentially give rise to innumerable pseudoexons, outnumbering the real ones. Nonetheless, these are efficiently ignored by the splicing machinery, a process yet to be understood completely. Although numerous 5' splice site-like sequences functioning as splicing silencers have been found to be enriched in predicted human pseudoexons, the lack of active pseudoexons pose a fundamental challenge to how these U1snRNP-binding sites function in splicing inhibition. Here, we address this issue by focusing on a previously described pathological ATM pseudoexon whose inhibition is mediated by U1snRNP binding at intronic splicing processing element (ISPE), composed of a consensus donor splice site. Spliceosomal complex assembly demonstrates inefficient A complex formation when ISPE is intact, implying U1snRNP-mediated unproductive U2snRNP recruitment. Furthermore, interaction of SF2/ASF with its motif seems to be dependent on RNA structure and U1snRNP interaction. Our results suggest a complex combinatorial interplay of RNA structure and trans-acting factors in determining the splicing outcome and contribute to understanding the intronic splicing code for the ATM pseudoexon.

Indexed as

RNA SplicingAtaxia TelangiectasiaAtaxia Telangiectasia Mutated ProteinsBase SequenceBinding SitesCell Cycle ProteinsDNA-Binding ProteinsDNA PrimersExonsHeterogeneous Nuclear Ribonucleoprotein A1Heterogeneous-Nuclear Ribonucleoprotein Group A-BHumansIntronsModels, BiologicalMolecular Sequence DataNuclear ProteinsAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Binding ProteinsDNA PrimersHeterogeneous Nuclear Ribonucleoprotein A1Heterogeneous-Nuclear Ribonucleoprotein Group A-BNuclear ProteinsProtein Serine-Threonine KinasesRecombinant ProteinsRibonucleoprotein, U1 Small NuclearRibonucleoprotein, U2 Small NuclearRNA-Binding ProteinsRNA PrecursorsRNA Splice SitesSerine-Arginine Splicing FactorsTumor Suppressor Proteins

Identifiers

PMID20094034
PMCPMC2829169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.